Integer Holdings Corporation
ITGR
株式のランク
#3854
Integer Holdings Corporation functions as a global leader in outsourced medical... Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
株価
$126.70
最終同期: 2026-10-16
時価総額
$4.31B
変化（1日）
-0.02%
変化（1年）
20.86%
国
US
取引 Integer Holdings Corporation (ITGR)
カテゴリー
Healthcare
Integer Holdings Corporation（ITGR）の営業利益率
October 2026 時点の営業利益率 TTM: 9.47%
Integer Holdings Corporation の最新の財務報告と株価によると、現在の営業利益率（TTM）は 9.47% です。2023 年末時点では 10.48% でした。
Integer Holdings Corporation の営業利益率の履歴（2000 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 9.47% | -21.93% |
| 2024 | 12.13% | 15.74% |
| 2023 | 10.48% | 18.82% |
| 2022 | 8.82% | -20.61% |
| 2021 | 11.11% | -1.16% |
| 2020 | 11.24% | -10.30% |
| 2019 | 12.53% | -2.11% |
| 2018 | 12.80% | 34.17% |
| 2017 | 9.54% | 22.15% |
| 2016 | 7.81% | -29.00% |
| 2015 | 11.00% | 19.05% |
| 2014 | 9.24% | 131.00% |
| 2012 | 4.00% | -63.13% |
| 2011 | 10.85% | -16.09% |
| 2010 | 12.93% | 102.66% |
| 2009 | 6.38% | 1.59% |
| 2007 | 6.28% | -23.88% |
| 2006 | 8.25% | 17.86% |
| 2005 | 7.00% | -47.99% |
| 2004 | 13.46% | -15.56% |
| 2003 | 15.94% | -3.45% |
| 2001 | 16.51% | 12.08% |
| 2000 | 14.73% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 17.03% | -98.20% |
US
|
|
| 17.86% | -98.11% |
IE
|
|
| 22.03% | -97.67% |
US
|
|
| 21.46% | -97.73% |
US
|
|
| 0.00% | - |
DE
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。